Mouse models of Alzheimer's disease

被引:219
作者
Hall, Alicia M.
Roberson, Erik D. [1 ]
机构
[1] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
关键词
Alzheimer's disease; Amyloid-beta; Presenilin; Tau; Apolipoprotein E (ApoE); Behavior; Transgenic; AMYLOID-PRECURSOR-PROTEIN; HEREDITARY CEREBRAL-HEMORRHAGE; APOLIPOPROTEIN-E GENOTYPE; TRIPLE-TRANSGENIC MODEL; GENE-TARGETED MICE; A-BETA PRODUCTION; HUMAN PRESENILIN-1; MEMORY DEFICITS; WILD-TYPE; NEUROFIBRILLARY TANGLES;
D O I
10.1016/j.brainresbull.2011.11.017
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is the most common cause of dementia, affecting 35 million people today. The search for new treatments is made ever more urgent by prospects for increasing prevalence due to population aging. Mouse models are one of the most important research tools for finding new treatments for AD. Here, we review those models. We begin by briefly reviewing the AD genetics on which mouse models are based and then consider the most common mouse models of AD, including mice transgenic for human amyloid precursor protein (hAPP) and beta-amyloid (A beta), mice expressing mutant presenilin genes, mice modeling tau's role in AD, and apolipoprotein E models. The discussion highlights key features and important differences between these mouse models. We conclude with a discussion about the role of AD mouse models in the translational pipeline. (C) 2011 Published by Elsevier Inc.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 183 条
  • [41] Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes
    Duff, K
    Knight, H
    Refolo, LM
    Sanders, S
    Yu, X
    Picciano, M
    Malester, B
    Hutton, M
    Adamson, J
    Goedert, M
    Burki, K
    Davies, P
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (02) : 87 - 98
  • [42] Increased amyloid-beta 42(43) in brains of mice expressing mutant presenilin 1
    Duff, K
    Eckman, C
    Zehr, C
    Yu, X
    Prada, CM
    Pereztur, J
    Hutton, M
    Buee, L
    Harigaya, Y
    Yager, D
    Morgan, D
    Gordon, MN
    Holcomb, L
    Refolo, L
    Zenk, B
    Hardy, J
    Younkin, S
    [J]. NATURE, 1996, 383 (6602) : 710 - 713
  • [43] Alzheimer transgenic mouse models come of age
    Duff, K
    [J]. TRENDS IN NEUROSCIENCES, 1997, 20 (07) : 279 - 280
  • [44] Reconstitution of γ-secretase activity
    Edbauer, D
    Winkler, E
    Regula, JT
    Pesold, B
    Steiner, H
    Haass, C
    [J]. NATURE CELL BIOLOGY, 2003, 5 (05) : 486 - 488
  • [45] Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041
  • [46] FAD mutant PS-1 gene-targeted mice:: Increased Aβ42 and Aβ deposition without APP overproduction
    Flood, DG
    Reaume, AG
    Dorfman, KS
    Lin, YG
    Lang, DM
    Trusko, SP
    Savage, MJ
    Annaert, WG
    De Strooper, B
    Siman, R
    Scott, RW
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (03) : 335 - 348
  • [47] Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model
    Fryer, JD
    Simmons, K
    Parsadanian, M
    Bales, KR
    Paul, SM
    Sullivan, PM
    Holtzman, DM
    [J]. JOURNAL OF NEUROSCIENCE, 2005, 25 (11) : 2803 - 2810
  • [48] ALZHEIMER-TYPE NEUROPATHOLOGY IN TRANSGENIC MICE OVEREXPRESSING V717F BETA-AMYLOID PRECURSOR PROTEIN
    GAMES, D
    ADAMS, D
    ALESSANDRINI, R
    BARBOUR, R
    BERTHELETTE, P
    BLACKWELL, C
    CARR, T
    CLEMENS, J
    DONALDSON, T
    GILLESPIE, F
    GUIDO, T
    HAGOPIAN, S
    JOHNSONWOOD, K
    KHAN, K
    LEE, M
    LEIBOWITZ, P
    LIEBERBURG, I
    LITTLE, S
    MASLIAH, E
    MCCONLOGUE, L
    MONTOYAZAVALA, M
    MUCKE, L
    PAGANINI, L
    PENNIMAN, E
    POWER, M
    SCHENK, D
    SEUBERT, P
    SNYDER, B
    SORIANO, F
    TAN, H
    VITALE, J
    WADSWORTH, S
    WOLOZIN, B
    ZHAO, J
    [J]. NATURE, 1995, 373 (6514) : 523 - 527
  • [49] Of Mice and Men Bridging the Translational Disconnect in CNS Drug Discovery
    Geerts, Hugo
    [J]. CNS DRUGS, 2009, 23 (11) : 915 - 926
  • [50] Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype?
    Gerlai, R
    [J]. TRENDS IN NEUROSCIENCES, 1996, 19 (05) : 177 - 181